A detailed history of Cubist Systematic Strategies, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 116,081 shares of ORGO stock, worth $369,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
116,081
Previous 94,705 22.57%
Holding current value
$369,137
Previous $265,000 24.91%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.42 - $3.24 $51,729 - $69,258
21,376 Added 22.57%
116,081 $331,000
Q2 2024

Aug 14, 2024

BUY
$2.28 - $3.03 $201,038 - $267,170
88,175 Added 1350.31%
94,705 $265,000
Q1 2024

May 15, 2024

BUY
$2.61 - $4.49 $17,043 - $29,319
6,530 New
6,530 $18,000
Q2 2023

Aug 14, 2023

SELL
$1.9 - $4.3 $21,352 - $48,323
-11,238 Reduced 20.36%
43,946 $145,000
Q1 2023

May 15, 2023

BUY
$1.89 - $2.93 $104,297 - $161,689
55,184 New
55,184 $117,000
Q3 2022

Nov 14, 2022

SELL
$3.14 - $6.43 $557,560 - $1.14 Million
-177,567 Reduced 82.48%
37,713 $122,000
Q2 2022

Aug 15, 2022

SELL
$4.74 - $8.15 $317,793 - $546,416
-67,045 Reduced 23.75%
215,280 $1.05 Million
Q1 2022

May 16, 2022

BUY
$6.47 - $9.57 $1.6 Million - $2.36 Million
246,660 Added 691.6%
282,325 $2.15 Million
Q4 2021

Feb 14, 2022

BUY
$9.02 - $13.5 $154,368 - $231,039
17,114 Added 92.25%
35,665 $330,000
Q3 2021

Nov 15, 2021

SELL
$13.71 - $17.18 $2.35 Million - $2.95 Million
-171,631 Reduced 90.25%
18,551 $264,000
Q2 2021

Aug 16, 2021

BUY
$14.92 - $23.23 $977,812 - $1.52 Million
65,537 Added 52.58%
190,182 $3.16 Million
Q1 2021

May 17, 2021

BUY
$7.33 - $21.06 $637,827 - $1.83 Million
87,016 Added 231.25%
124,645 $2.27 Million
Q4 2020

Feb 16, 2021

BUY
$3.63 - $7.53 $136,593 - $283,346
37,629 New
37,629 $283,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $416M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.